Bioaccessibility and Pharmacokinetics of a Commercial Saffron (Crocus sativus L.) Extract

Table 1

Chromatographic identification of the main bioactive components found in affron® by HPLC coupled to the mass detector in ESI+ and ESI−.

RT (minutes)	Compound	Maximum UV-Vis (nm)	ESI+ (m/z)	ESI− (m/z)
7.6	Picrocrocin	251	511.2; 365.1; 353.2; 337.1; 329.1; 185.1; 159.9; 151.1; 123.0; 81.3	1480.8; 667.2; 517.1; 385.0; 181.2; 153.1
11.5	Kaempferol diglucoside	266; 347	633.2; 347.1	609.0; 284.0
22.1	trans-crocin-4	261; 323; 441; 464	999.4; 675.2; 511.2; 347.1	1336.2; 651.2; 326.8; 283.1
26.7	trans-crocin-3	261; 323; 440; 463	837.4
30.7	trans-crocin-2′	261; 328; 440; 464	675.2; 593.0; 513.2; 351.1; 130.1; 102.2; 74.1
33.9	Safranal	313	—	—
36.2	cis-crocin-4	225; 262; 325; 433; 456	999.4; 821.3; 668.3; 611.0; 391.0; 347.0	651.2
37.6	trans-crocin-2	260; 322; 433; 458	675.2; 541.1	651.2; 327.1; 311.1; 283.1

Bold numbers indicate coincidences in the molecular fractions obtained in [30].